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Aortic stiffness is associated with cardiac
function and cerebral small vessel disease
in patients with type 1 diabetes mellitus:
assessment by magnetic resonance imaging
Abstract Objective: To evaluate,
with the use of magnetic resonance
imaging (MRI), whether aortic pulse
wave velocity (PWV) is associated
with cardiac left ventricular (LV)
function and mass as well as with
cerebral small vessel disease in
patients with type 1 diabetes mellitus
(DM). Materials and methods: We
included 86 consecutive type 1 DM
patients (49 male, mean age
46.9±11.7 years) in a prospective,
cross-sectional study. Exclusion
criteria included aortic/heart disease
and general MRI contra-indications.
MRI of the aorta, heart and brain was
performed for assessment of aortic
PWV, as a marker of aortic stiffness,
systolic LV function and mass, as well
as for the presence of cerebral white
matter hyperintensities (WMHs),
microbleeds and lacunar infarcts.
Multivariate linear or logistic
regression was performed to analyse
the association between aortic PWV
and outcome parameters, with
covariates defined as age, gender,
mean arterial pressure, heart rate,
BMI, smoking, DM duration and
hypertension. Results: Mean aortic
PWV was 7.1±2.5 m/s. Aortic PWV
was independently associated with LV
ejection fraction (ß=-0.406,
P=0.006), LV stroke volume
(ß=-0.407, P=0.001), LV cardiac
output (ß=-0.458, P=0.001), and with
cerebral WMHs (P<0.05). There
were no independent associations
between aortic stiffness and LV mass,
cerebral microbleeds or lacunar
infarcts. Conclusion: Aortic stiffness
is independently associated with
systolic LV function and cerebral
WMHs in patients with type 1 DM.
Keywords Aorta . Magnetic
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Introduction
Type 1 diabetes mellitus (DM) patients show functional and
structural alterations of the arterial vessel wall, resulting in
arterial stiffness [1, 2]. Arterial stiffening has been described
as an early phenomenon in subjects with type 1 DM, already
apparent before clinical onset of cardiovascular (CV)
complications, and also as an independent predictor of
overt CV disease and mortality [3]. Therefore, arterial
stiffening may be related to the pathogenesis of CV
complications in type 1 DM. This notion could be
substantiated if an independent relationship could be
established between arterial stiffness and cardiac function
in type 1 DM. Furthermore,CV complications in type 1 DM
also involve small vessel disease in the brain, and if a
relationship between arterial stiffness and cerebral small
vessel disease could be established as well, this would
support the importance of arterial stiffness in CV complica-
tions in type 1 DM. An integrated study investigating the
relationship between arterial stiffness, cardiac function and
cerebral small vessel disease has not been performed in type
1D Ms of a r .
Stiffening of the aorta affects cardiac function by
increasing the cardiac afterload and reducing diastolic
coronary artery perfusion [4]. Myocardial perfusion might
fail to compensate for the increased metabolic energy
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2300 RC Leiden, The Netherlandsdemand, resulting in an impaired myocardial contractility
function [5]. Furthermore, stiffness of the central large
arteries results in deficient absorption of the pulse wave.
This high pulsatile flow is transmitted from the aorta to the
brain causing damage to the endothelial and smooth muscle
cells, disrupting the cerebral small vessels [6, 7]. Also,
aortic stiffness may represent coronary and cerebral
endothelial dysfunction or wall thickening caused by
shared underlying mechanisms.
As aortic function plays a central role in maintaining
adequate perfusion of both the heart and the brain, we
hypothesized that aortic stiffness is associated with
cardiac function as well as with cerebral small vessel
disease in DM patients. To our knowledge, no previous
magnetic resonance imaging (MRI) studies have eval-
uated the relationship between aortic function, cardiac
function and cerebral small vessel disease in one
comprehensive protocol. MRI is a non-invasive tool for
the accurate assessment of aortic pulse wave velocity
(PWV) [8] as a marker of aortic stiffness [9]. Notably,
MRI is not dependent on geometric assumptions about the
aortic path length unlike ultrasound techniques [10].
Furthermore, MRI is well suited to assess cardiac LV
function [11]. Moreover, MRI is a validated technique for
the detection of cerebral small vessel disease manifesting
as white matter hyperintensities (WMHs) [12], micro-
bleeds [13] and lacunar infarcts [14].
Therefore, the purpose of the present study was to use a
comprehensive MRI protocol to evaluate whether aortic
PWV is associated with cardiac LV function and mass as
well as with cerebral small vessel disease in patients with
type 1 DM.
Materials and methods
Study participants
Between February 2008 and February 2009, consecutive
patients with type 1 DM were recruited from our local
outpatient clinic of the university medical centre. For
inclusion, patients had to be older than 18 years and
diagnosed with type 1 DM. A total of 86 patients
(49 men, 37 women; mean age 46.9 ± 11.7 years) gave
written informed consent to participate in the study and
were prospectively included. Exclusion criteria included
congenital aortic/heart disease, evidence of aortic or
heart disease as evaluated by means of cardiac
auscultation and ECG, and standard contra-indications
to MRI such as claustrophobia, pacemaker and metal
implantations.
Information about patient characteristics was obtained
by means of a standardised interview and physical and
laboratory examinations. Diabetes duration was estimated
as the time passed between the reported age of diagnosis
and the MRI examination. Body mass index (BMI) was
calculated from body length and mass at the time of MRI.
Blood pressure and heart rate were measured after MRI
using a semi-automated sphygmomanometer (Dinamap,
Critikon, Tampa, FL, USA, validated to ANSI/AAMI SP10
criteria). Pulse pressure was defined as the difference
between systolic and diastolic blood pressure. Mean arterial
pressure (MAP) was calculated by adding diastolic blood
pressure to one-third of the pulse pressure. Smoking was
defined as non-smoker or a current smoker. Hypertension
was defined as the use of anti-hypertensive medication.
Glycated haemoglobin (HbA1c), high-density lipoprotein
(HDL), low-density lipoprotein (LDL), total cholesterol,
triglycerides and C-reactive protein were determined. The
albumin excretion ratio was calculated using the micro-
albumin and creatinine concentrations in the urine.
The study was approved by the local medical ethics
committee, and the study was conducted according to the
principles in the Declaration of Helsinki.
Magnetic resonance imaging
Aortic and cardiac imaging was performed using 1.5 Tesla
MRI (NT 15 Gyroscan Intera; Philips Medical Systems,
Best, the Netherlands). All brain examinations were
performed on 3.0 Tesla MRI (Achieva; Philips Medical
Systems, Best, the Netherlands).
For the evaluation of aortic stiffness, aortic PWV was
determined using a previously described protocol [15]. In
short,ascoutviewoftheaortawasperformed.Twovelocity-
encoded images were obtained: one perpendicular to the
aorta atthe level of the pulmonary trunk,and one atthe level
of the abdominal descending aorta 7.5 cm beneath the
diaphragm. This resulted in through-plane flow measure-
ments of the ascending and descending aorta at those levels.
AorticPWVwascalculatedfortheaortaasΔx/Δt,whereΔx
is the aortic path length between the two measurement sites
andΔtisthetimedelaybetweenthearrivalsofthefootofthe
pulse wave at the respective measurement sites. Data were
analysed with MASS/FLOW (Medis, Leiden, the Nether-
lands) by a single observer (S.v.E., 2 years of experience in
cardiac MRI) supervised by a senior researcher (J.W., 13 years
of experience in cardiac MRI).
For the assessment of systolic LV function and LV mass,
the entire heart was imaged in short-axis orientation as
described previously [11]. Endocardial and epicardial LV
borders were manually traced on short-axis cine images
using the software package MASS. Ejection fraction (EF),
stroke volume (SV), cardiac output (CO), LVend-diastolic
volume (LV ED volume), LVend-systolic volume (LV ES
volume) and LV end-diastolic mass (LV ED mass) were
assessed. Volumes and mass were indexed (i) for body
surface area (BSA). All manual contour drawings were
performed by a researcher (S.v.E., 2 years of experience in
cardiac MRI), with supervision of a radiologist (L.K., 12
years of experience in cardiac MRI).
1133For evaluation of cerebral small vessel disease a spin-
echo T2-weighted image, a fluid-attenuated inversion
recovery (FLAIR) image and a T2*-weighted gradient
echo sequence were assessed. WMHs were defined as areas
of brain parenchyma with increased signal on T2-weighted
and FLAIR images without mass effect. WMHs were
distinguished as either periventricular (pv) WMHs or
subcortical (sc) WMHs because of the different pathogen-
esis involved [16]. WMHs were classified according to
Fazekas et al. [16]. For statistical analysis subjects were
divided into those with normal (0) versus abnormal (1)
amounts of pv and sc WMHs. Figure 1 demonstrates a case
example with presence of pv and sc WMHs on a FLAIR
sequence. Microbleeds were defined as focal, nodular areas
of signal loss in brain parenchyma on T2* images that are
invisible or smaller on T2-weighted spin echo images [17].
Microbleeds were scored as absent (0) or present (1).
Lacunar brain infarcts were defined as small (but >3 mm in
size) cavities within the brain parenchyma, with similar
signal intensity to that of cerebrospinal fluid on all pulse
sequences, surrounded by an area of high signal intensity on
T2 and FLAIR images [18, 19]. Their presence was defined
on a binary scale: absent (0) or present (1). WMHs,
microbleeds and lacunar infarcts were visually scored by
consensus reading by a researcher (S.v.E., 1 year of
experience in neuroradiology) and a senior neuroscientist
(J.v.d.G., 15 years of experience in neuroradiology) or
a neuroradiologist (M.v.B., 15 years of experience in
neuroradiology).
Statistical analysis
Statistical analysis was performed using SPSS for
Windows (version 16.0; SPSS, Chicago, IL, USA). Data
are expressed as mean ± standard deviation, unless
stated otherwise. Aortic PWV values were non-normally
distributed (Kolmogorov-Smirnov test of normality,
P=0.002). Spearman correlation analysis was performed
to analyse the association between aortic PWV and
continuous outcome parameters. Spearman correlation
coefficients (r) and P values are reported. Univariate
logistic regression was performed to analyse the asso-
ciation between aortic PWV and dichotomous outcome
parameters. Odds ratios (OR), 95% confidence intervals
(CI) and P values are reported. For adjustment of
confounding factors, defined as age, gender, MAP, heart
rate, BMI, smoking, DM duration and hypertension,
these covariates were entered into a multivariate linear
or logistic regression model. Associations between
cardiac parameters indexed for BSA were not corrected
for BMI.
Results
The characteristics of the study population are described
in Table 1. All MRI examinations were successfully
performed without any adverse events. Eighty-six
patients with type 1 DM were included, with a mean
age of 46.9±11.7 years. The mean HbA1c values were
7.7±1.0%.
Mean aortic PWV was 7.11 ± 2.51 m/s. Aortic PWV was
significantly associated with age (r=0.674, P<0.001), DM
duration (r=0.299, P=0.006), BMI (r=0.317, P=0.003),
systolic blood pressure (r=0.484, P<0.001), pulse
pressure (r=0.509, P<0.001), MAP (r=0.339, P=
0.001) and use of antihypertensive medication (OR=
1.278, P=0.017). There were no statistically significant
associations between aortic PWV and laboratory mar-
kers (Table 1).
Associations between aortic PWV and cardiac LV
function and mass
The mean values of cardiac LV parameters and the
associations with aortic PWV are summarised in Table 2.
After statistical correction for confounder’s age, gender,
MAP, heart rate, BMI, smoking, DM duration and
hypertension, aortic PWV was found to be significantly
associated with systolic LV parameters: LV EF (ß=-0.402,
P=0.006), LV SVi (ß=-0.407, P=0.001) and LV COi
(ß=-0.458, P=0.001). The inverse association between
aortic PWVand LV SVi is illustrated in Fig. 2. There was
no statistically significant association between aortic PWV
and LV mass.
Fig. 1 A 66-year-old male patient with type 1 diabetes mellitus with
abnormal white matter hyperintensities (WMHs) on a FLAIR
sequence and high aortic pulse wave velocity of 8.9 m/s. The four
arrows point to periventricular WMHs, the arrowhead indicates an
example of a subcortical WMH
1134Associations between aortic PWV and cerebral small
vessel disease
According to their Fazekas score, 16 (18.6%) patients
showed pv WMHs and 38 (44.2%) patients were diagnosed
with sc WMHs. In 7 (8.1%) DM patients, microbleeds were
detected. Two patients (2.3%) showed lacunar infarcts on
brain MRI. The associations between aortic PWV and
parameters of cerebral small vessel disease are summarised
in Table 2. Univariate logistic regression analysis showed
that aortic PWV was significantly associated with all MRI
parameters of cerebral small vessel disease.
After statistical adjustment for confounding factors,
aortic PWV was significantly associated with pv WMHs
(OR=1.425, 95% CI=1.003–2.026, P<0.05) and sc
WMHs (OR=1.479, 95% CI=1.063–2.058, P=0.02). In
Fig. 3, aortic PWV in patients with type 1 DM with and
without pv WMHs is presented in boxplots showing higher
aortic PWV in patients with pv WMHs compared with
patients without pv WMHs.
Discussion
The purpose of the present study was to evaluate whether
aortic PWV is associated with cardiac LV function and
mass as well as with cerebral small vessel disease in
patients with type 1 DM using a comprehensive MRI
protocol.
The main findings of our study are that aortic stiffness in
patients with type 1 DM is inversely associated with systolic
LV function and is associated with cerebral WMHs,
independently of age, gender, MAP, heart rate, BMI,
smoking, DM duration and hypertension. No independent
association between aortic stiffness and LV mass, cerebral
microbleeds or lacunar infarcts was found.
This study is the first to report an integrated approach for
detecting the relationship among arterial stiffness, cardiac
function and cerebral small vessel disease. Indeed, in this
cohort of relatively young type 1 DM patients, aortic
stiffness was found to be inversely associated with systolic
LV function and with WMHs. Patients with type 1 DM are
at increased risk of developing systolic LV dysfunction,
with subsequent progressive heart failure and premature
death [20]. In addition, it is known that WMHs may
progress and become manifest over time [21, 22] but also
that individuals with WMHs benefit from secondary stroke
prevention therapies [23]. We hypothesized that PWV as
measured in the aorta by MRI may be a marker or risk
factor for generalised vascular disease that might poten-
tially be treated. Interestingly, this association between
PWV and MRI manifestations of cardiac function and
cerebral small vessel disease was independent of many
major risk factors such as age and hypertension, suggesting
that aortic stiffness might have an independent pathophy-
siological mechanism.
The present MRI data show that in type 1 DM patients
aortic stiffness was inversely related to systolic LV function.
To our knowledge, this is the first study to report a
relationship between systolic LV function and aortic
stiffness in a type 1 DM population. In our study population,
the LVejection fraction was in the normal range [24], which
might emphasise an important role of aortic stiffness in
cardiac function already manifesting before occurrence of
cardiac dysfunction or failure and compensatory remodel-
ling. High blood pressure is strongly associated with LV
hypertrophy [25]. However, in type 1 DM patients the
presence of LV hypertrophy is not a well-known phenom-
enon[26,27].Thereforeitismorelikelythatinpatientswith
hypertension increased aortic stiffness is associated with LV
hypertrophy [28, 29]. Our study on type 1 DM patients is in
line with these findings; no relationship between aortic
PWV and LV mass was found in a relatively young type 1
DM population with well-treated hypertension. Further-
more, a statistical correction for hypertension was per-
formed.
In the present study, aortic PWV was independently
associated with pv and sc WMHs. Although increased
Table 1 Patient characteristics
Patients
(n=86)
Association with aortic
PWV
Characteristics
Male gender 49 (57%) P=0.586
Age (years) 46.9±11.7 r=0.674, P<0.001*
Diabetes duration (years) 23.8±11.0 r=0.299, P=0.006*
BMI (kg/m
2) 25.7±3.4 r=0.317, P=0.003*
Systolic blood pressure
(mmHg)
132±18 r=0.484, P<0.001*
Diastolic blood pressure
(mmHg)
74±9 P=0.164
Pulse pressure (mmHg) 58±16 r=0.509, P<0.001*
Mean arterial pressure
(mmHg)
93±11 r=0.339, P=0.001*
Heart rate (beats/min) 71±10 P=0.286
Current smokers 10 (12%) P=0.867
Use of antihypertensive
medication
31 (36%) OR=1.278, P=0.017*
Laboratory markers
HbA1c (%) 7.7±1.0 P=0.597
HDL cholesterol (mmol/l) 1.6±0.5 P=0.905
LDL cholesterol (mmol/l) 2.8±0.9 P=0.154
Total cholesterol (mmol/l) 4.7±1.0 P=0.050
Triglycerides (mmol/l) 1.2±0.8 P=0.193
C-reactive protein (mg/l) 2.1±2.1 P=0.549
Microalbumin/Creatinine
ratio (μg/μmol)
1.2±2.5 P=0.145
Data are presented as mean ± standard deviation or n (%). Spearman
rho (r) and P values are presented. *P value<0.05
PWV Pulse wave velocity, BMI body mass index, HbA1c glycated
haemoglobin, HDL high-density lipoprotein, LDL low-density
lipoprotein
1135arterial stiffness in DM was related to microvascular
complications of the kidneys and the retina in a previous
study [3], the current study is the first to report on the
potential relation between aortic stiffness and small vessel
disease inthebraininpatientswithtype1DM.Interestingly,
this relationship between aortic stiffness and WMHs was
independent of hypertension, a finding that has been
reported recently [30], and independent of age as described
before [31], suggesting an independent pathophysiological
mechanism for aortic stiffness and WMHs in patients with
type 1 DM.
No independent relationship was found between aortic
stiffness and microbleeds. It is plausible that instead of a
haemodynamic effect, other mechanisms including altered
glucoregulation and microvascular changes by advanced
glycation end products are involved in the development of
microbleeds in DM patients [32, 33]. The low prevalence
of lacunar infarcts (n=2) in our study population may have
hampered the statistical analyses.
In addition to arterial stiffness being a predictor of (fatal)
myocardial infarction andstroke [3], our study results show
Table 2 Aortic PWV and the associations with MRI parameters
Univariate analysis Multivariate analysis
Cardiac MRI parameters Mean ± sd rP value ß P value
Aortic PWV (m/s) 7.11±2.51
LV EF (%) 59.7±6.1 0.201 −0.409 0.006*
LV SV (i) (ml/m
2) 46.7±8.1 −0.376 <0.001* −0.407 0.001*
LV CO (i) (ml/m
2) 3100±542 −0.416 <0.001* −0.457 0.001*
LV ED volume (i) (ml/m
2) 78.4±12.7 −0.310 0.004* 0.066
LV ES volume (i) (ml/m
2) 31.6±7.8 0.327 0.349
LV ED mass (i) (g/m
2) 47.4±9.7 0.848 0.666
Brain MRI parameters Number OR P value OR P value
Periventricular WMHs 16 (18.6%) 1.452 0.002* 1.426 0.048*
Subcortical WMHs 38 (44.2%) 1.408 0.004* 1.479 0.020*
Microbleeds 7 (8.1%) 1.301 0.042* 0.976
Lacunar infarct 2 (2.3%) 1.492 0.036* 0.997
Data are presented as mean ± standard deviations or n (%). Spearman’s rho (r), standardised ß values, odds ratios (OR) and P values are
reported for the association with aortic PWV, in univariate analysis or multivariate analysis with the covariates age, gender, MAP, heart rate,
BMI, smoking, DM duration and hypertension. *P value<0.05
PWV Pulse wave velocity, MRI magnetic resonance imaging, LV left ventricular, EF ejection fraction, SV stroke volume, CO cardiac output,
ED end-diastolic, ES end-systolic, i indexed for body surface area, WMHs white matter hyperintensities
Fig. 3 These boxplots show that type 1 diabetes mellitus patients
with periventricular white matter hyperintensities in the brain show
higher aortic pulse wave velocity values compared with those
without periventricular white matter hyperintensities
Fig. 2 There is an inverse relation between aortic pulse wave
velocity and systolic left ventricular (LV) function in patients with
type 1 diabetes mellitus (n=86)
1136that aortic stiffness is associated with reduced cardiac
function and cerebral small vessel disease as shown by
MRI. Of note, assessment of aortic PWV is currently not
part of the clinical routine assessment in DM patients. Our
study results suggest that aortic PWV could be useful in the
cardiovascular risk screening of patients with type 1 DM, if
longitudinal studies confirm our initial observations and
establish their prognostic implications in patients with type
1 DM.
As the study design is cross-sectional, a causal relation-
ship between aortic PWV and systolic LV function or
WMHs cannot be determined. However, the present study
reveals that aortic stiffness reflects both cardiac function
and cerebral small vessel disease. In our study design, we
chose to measure aortic PWV with some distance of the
aortic bifurcation to avoid wave reflections from the aortic
bifurcation, which can corrupt the observer-independent
automatic assessment of the PWV [34]. However, more
refined analysis of thoracic and abdominal aortic segments
may allow local identification of aortic vessel wall
condition, and its relationship with cardiac function and
cerebral small vessel disease. A possible limitation of this
study is the lack of a healthy control group. However, the
main purpose of this study was to investigate the possible
relationship between aortic PWVand cardiac function and
mass as well as cerebral small vessel disease in type 1 DM
patients.
In conclusion, this study shows that in patients with type
1 DM stiffness of the aorta is independently associated with
systolic LV function as well as with cerebral WMHs. By
documenting that aortic stiffness reflects stages of both
cardiac function and cerebral small vessel disease, our
study results suggest that aortic PWVassessment might be
a useful marker of cardiac and cerebrovascular disease in
patients with type 1 DM. Future studies are needed to
assess the prognostic implications of our observations.
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